全球栓塞預防裝置市場：市場規模、佔有率和趨勢分析（2026-2032 年）

全球栓塞預防裝置市場報告

2025年全球栓塞預防裝置市場規模為1.34億美元。在預測期內，該市場預計將以1.1%的複合年成長率成長，到2032年達到1.44億美元。

• 這份關於全球栓塞預防裝置（EPD）市場的綜合報告涵蓋七個區域：北美、拉丁美洲、西歐、中東歐、中東、亞太地區和非洲。報告針對每個區域提供市場規模、銷售量分析和平均售價數據，並預測至2032年，從而對市場趨勢做出清晰且前瞻性的展望。本報告遵循附件範例文件的整體結構和最佳實踐流程，並根據EPD市場的具體臨床和商業性趨勢進行了調整。

本報告對全球EPD市場進行了詳細分析，包括截至2022年的歷史數據，以及銷售量、治療量、平均售價、市場規模、成長趨勢、市場佔有率和截至2032年的預測。報告中還包括主要區域市場主要企業的近期併購、公司簡介、產品系列和競爭分析。

該市場受手術量不斷成長和實際限制因素的雙重影響。正面的一面是，下肢動脈動脈粥狀硬化斑塊切除術和其他高風險周邊血管手術中持續使用血管內保護裝置（EPD）支撐了市場需求。同時，影像和導航技術的進步也使醫生能夠更有效地使用這些裝置。另一方面，頸動脈切除術的普及、醫生在血管內治療流程方面的培訓不足以及EPD和支架的捆綁銷售等阻礙因素仍然限制著市場規模的成長。

整體而言，全球栓塞預防器材市場保持穩定，但成長較為溫和。儘管這些器械在某些手術和患者群體中仍然發揮著重要作用，但其更廣泛的應用將取決於醫生培訓、醫保報銷環境、手術流程以及持續改進易用性和臨床可靠性的器械研發。

市場概覽

全球栓塞預防裝置市場涵蓋用於防止血管內治療過程中栓塞碎片向下游移動，從而避免中風、缺血或遠端血管閉塞等併發症的裝置。這些裝置在血管介入治療中尤其重要，因為斑塊碎裂或血栓物質可能造成嚴重的臨床風險。

從歷史上看，栓塞保護裝置（EPD）最重要的作用在於頸動脈置入術。在頸動脈手術中，術中保護是至關重要的安全考量，因為栓塞碎片可能會到達大腦。隨著時間的推移，EPD 的應用範圍已擴展到某些下肢周邊動脈動脈粥狀硬化斑塊切除術術以及其他可能因病變破壞而釋放顆粒物的病例。雖然這拓寬了此類產品的臨床應用範圍，但市場仍主要圍繞著相對較少的適應症。

心內膜保護裝置 (EPD) 市場與其應用的手術類別密切相關。 EPD 本身並不獨立產生需求，而是取決於置入術、下肢動脈動脈粥狀硬化斑塊切除術、某些腎臟或周邊血管介入治療相關的成長，以及在某些產品系列中，與結構性心臟疾病手術相關的腦保護。因此，市場成長與醫師偏好、臨床指引的變化以及血管內保護治療的整體普及程度密切相關。

此外，隨著血管介入技術的快速發展，這個市場也不斷演進。影像和導航工具的進步正在提升臨床醫生評估解剖結構、定位器械以及管理手術風險的能力。這一趨勢有助於推動下一代電子保護裝置（EPD）的研發，尤其是在更複雜的手術中，即時血管評估能夠改善決策並減少併發症。

總體而言，全球栓塞預防設備市場仍然是一個安全至關重要的領域。其未來發展與其說是取決於手術量的激增，不如說是取決於醫生如何在特定介入治療類型中權衡風險、工作流程複雜性、報銷以及栓塞預防的價值。

市場促進因素

下肢動脈動脈粥狀硬化斑塊切除術術

全球EPD市場的主要促進因素之一是抗栓塞裝置在下肢動脈動脈粥狀硬化斑塊切除術術的應用。頸動脈支架置入術後，這是EPD最常用的應用之一。在動脈動脈粥狀硬化斑塊切除術術中，抗栓塞對於某些介入性治療至關重要，尤其是在複雜性周邊動脈疾病的情況下，因為可能會釋放微碎片。

隨著全球人口老化，治療周邊動脈疾病的手術數量預計將會增加。這其中包括下肢血管的動脈粥狀硬化斑塊切除術，而下肢血管病變的嚴重程度、鈣化程度、以及複雜性都可能增加遠端栓塞的風險。隨著此類手術數量的增加，用於下肢手術的遠端栓塞裝置（EPD）的需求預計也會上升。這是推動該類別產品銷售成長的最顯著因素之一。

人口老化與周邊動脈疾病（PAD）的負擔

推動EPD市場發展的更廣泛因素是周邊血管疾病及其相關合併症負擔的日益加重。老年患者更容易出現斑塊、鈣化或其他複雜病變，在接受血管內治療時，他們可能受益於栓塞預防。由於該市場與這些更先進的手術密切相關，患者群體的老化間接支撐了對EPD的需求。

這種趨勢在周邊血管介入治療中尤其明顯，因為周邊動脈疾病（PAD）患者通常會合併糖尿病、腎臟疾病和其他危險因素，使治療更加複雜。隨著個案複雜性的增加，特定介入治療中預防栓塞措施的需求也隨之增加。

德國的高還款率

由於德國在相關介入領域較高的報銷率，它歷來是部分電子保護裝置（EPD）市場的重要驅動力。雖然這種情況並非在所有市場都相同，但德國市場尤其受益於血栓切除術或相關手術領域更強力的財政支持。這促進了更先進的血管內裝置的使用，即使在醫院成本控制較為緊張的情況下也是如此。

儘管醫保報銷機制正在發生變化，但德國歷來健全的健保體系一直是推動這些設備普及和使用的重要因素之一。在缺乏類似支援的市場，醫院往往更依賴私人醫療機構，或嚴格限制這些設備的使用。因此，德國的案例對於了解哪些地區在市場上的表現較佳尤為重要。

市場限制

子宮內膜切除術的推廣

全球EPD市場最大的限制因素是頸動脈切除術的持續廣泛應用。儘管CREST研究等試驗的數據影響了臨床模式，並促使頸動脈置入術置入術中採用了更嚴格的EPD要求，但切除術仍然是全球許多醫生治療頸動脈閉塞的首選治療方法。

這一趨勢意義重大，因為頸動脈置入術是推動EPD使用的主要手術類型之一。如果醫生繼續因為開放手術術後早期嚴重不利事件發生率較低而傾向於選擇開放性手術，那麼對EPD的需求將持續低迷。換言之，只要切除術仍是主流手術，該類別中的核心手術類型之一的成長速度就會放緩。

醫生缺乏培訓

另一個主要的阻礙因素是醫生培訓不足。神經科醫師和血管外科醫師未必接受過專門的血管內治療技術訓練。此外，使用栓塞預防裝置會增加手術難度，因為醫生必須同時操作治療裝置和預防裝置。這種複雜性的增加會阻礙該技術的廣泛應用，尤其是在病例數量較少的醫療機構或血管內治療技術不發達的地區。

訓練不足直接影響了科技的普及率。即使醫生理解栓塞預防的理論價值，他們往往不願意採用涉及額外操作步驟且需要更高技術水平的工作流程。這導致技術普及速度緩慢，市場成長也相對落後。

商品搭售和折扣

商品搭售也是該市場的一個重要限制因素。在許多市場，企業將抗栓塞裝置與頸動脈支架和其他相關產品捆綁銷售。雖然這有助於促進裝置普及和加強客戶關係，但也促使價格大幅下降，進而對電子防護裝置（EPD）市場的價值造成下行壓力。

在頸動脈支架市場尚不發達的國家，這是一個特別重要的問題。在這樣的環境下，供應商可能會採取激進的定價和包裝策略來維護其整體產品組合的市場地位。雖然這在某些情況下可能有助於提高產品銷量，但也可能抑制收入成長，並持續對平均售價造成下行壓力。

市場覆蓋範圍和數據範圍

定量研究範圍

市場規模、市佔率、市場預測、市場成長率、銷售量、平均售價。

定性研究範圍

市場促進因素和限制因素、成長趨勢、近期併購、公司概況、產品系列和主要競爭對手。

目標期

基準年：2025 年，歷史資料：截至 2022 年，預測：截至 2032 年。

按地區定位

北美洲、拉丁美洲、西歐、中歐和東歐、中東、亞太地區、非洲。

包含的資料類型

銷售量、平均售價、治療次數、市場規模和成長趨勢。

本報告旨在透過結合基於手術數量的市場規模計算、定價分析和實際臨床背景，為策略規劃和競爭基準分析提供支援。

目標市場及區隔

• 本報告涵蓋全球栓塞預防裝置市場，並按裝置類型進一步細分如下：

頸動脈栓塞預防裝置

這些裝置主要用於頸動脈置入術，以降低手術過程中發生腦栓塞和中風的風險。

腎栓塞預防裝置

這些裝置用於某些腎臟血管手術中，在這些手術中，防止栓塞碎片在臨床上非常重要。

下肢栓塞預防裝置

這些裝置用於某些周邊血管手術，特別是下肢動脈動脈粥狀硬化斑塊切除術，在治療病變過程中可能會釋放微碎片。

每個細分市場均根據銷售量、平均售價和總市場價值進行分析，並包括截至 2032 年的預測和截至 2022 年的歷史數據。這種細分反映了栓塞預防在治療中起著至關重要作用的關鍵血管領域。

競爭分析

美敦力於2015年1月透過收購柯惠醫療（Covidien）進入美國栓塞預防裝置市場，從而獲得了先前由ev3公司銷售的SpiderFX裝置。 SpiderFX的特點是帶有造影的帶狀物以輔助植入，以及穩定的編織濾芯設計。本產品已核准用於頸動脈、下肢和隱靜脈移植手術。到2025年，美敦力將繼續引領替代性栓塞預防裝置（EPD）市場，SpiderFX仍將是唯一核准用於下肢手術的獨立EPD。這使該公司在非頸動脈栓塞預防這一關鍵應用領域確立了獨特而強大的市場地位。

雅培血管於2006年透過收購Guidant的抗栓塞和頸動脈支架平台進入市場，成為首家提供核准用於頸動脈核准的栓塞保護裝置（EPD）的公司。憑藉這一先發優勢以及醫生的認可，雅培迅速在市場上確立了穩固的地位。產品不斷革新也進一步鞏固了這個地位。 Emboshield NAV6系統採用了改進的籃狀結構、回收功能以及專有的BareWire技術，實現了更獨立的導絲移動。此外，雅培也拓展了RX Accunet EPD的適應症，進一步鞏固了其在頸動脈介入治療領域的領先地位。

波士頓科學公司也是重要的競爭對手。其FilterWire EZ裝置用於頸動脈和隱靜脈移植手術，旨在透過均勻的微孔過濾器，在各種血管直徑範圍內提供栓塞保護，同時保持血流。 2018年，波士頓科學公司收購了Claret Medical公司，獲得了用於經導管主動脈瓣置換術（TAVR）的Sentinel腦栓塞預防系統，進一步增強了其豐富的產品系列。透過將Sentinel系統與其TAVR產品線結合，波士頓科學公司提高了產品組合的協同效應，並增強了其在栓塞保護介入治療領域的競爭力。

總體而言，競爭格局取決於每項手術的核准情況、設備認知度、商品搭售策略以及將栓塞預防整合到廣泛的血管和結構性心臟疾病組合中的能力。

科技和醫療治療的發展趨勢

EPD市場最顯著的趨勢之一是將先進的影像和導航工具整合到血管內治療流程中。改進的即時視覺化功能使醫生能夠在介入治療過程中更準確地評估解剖結構、斑塊負荷和器械位置。

這一趨勢有助於更精準地預防栓塞，並增強臨床醫生在處理複雜病例時的信心。在此背景下，血管內超音波和光學同調斷層掃描（OCT）等技術的重要性日益凸顯。

另一個重要趨勢是下肢保護在動脈粥狀硬化斑塊切除術中的持續作用。隨著動脈粥狀硬化斑塊切除術在某些周邊血管疾病病例的應用不斷擴大，下肢手術中使用血管保護裝置仍然是一個重要的研究領域。

此外，產品系列組合的商品搭售正日益影響市場格局。心肺復甦術產品通常並非以獨立設備銷售，而是與支架、動脈粥狀硬化斑塊切除術系統或結構性心臟疾病治療產品組合銷售，這會影響定價和市場滲透率。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

一份長達 66 頁的詳細市場分析、市場區隔和預測數據報告。

附錄：調查方法和縮寫詞彙表。

這份報告的意義

到 2032 年，全球栓塞預防器材市場中最穩定的機會在哪裡？

預計各區域頸動脈、腎臟和下肢的 EPD 區段會出現哪些趨勢？

下肢動脈動脈粥狀硬化斑塊切除術的發展和醫師訓練的增加，將在未來科室需求中扮演怎樣的角色？

切除術的偏好、商品搭售治療和報銷條件如何限制市場擴張？

在頸動脈和下肢栓塞預防領域，哪些競爭對手佔據了最強的市場佔有率，他們是如何實現產品差異化的？

影像和導航技術的進步將如何影響栓塞預防裝置發展的下一階段？

iData Research 的《全球栓塞預防器材市場報告》透過詳盡的市場規模、價格分析、市場細分和競爭格局信息，解答了這些問題。利用這份報告，您可以比較和評估競爭對手，了解手術需求，並在專業且具有重要臨床意義的血管器械市場中製定策略。

目錄

圖表清單

調查方法

• 第一步：計劃啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 第四步：進行初步調查
• 第五步：調查與分析：建立基準估計值
• 第六步：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟九：客戶回饋與市場監測

全球關稅的影響

栓塞預防裝置市場

• 執行摘要
  • 全球栓塞預防裝置市場概覽
  • 競爭分析
  • 目標程式
  • 目標市場
  • 目標區域
• 介紹
  • 保護機制
• 手術次數
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 栓塞預防裝置的整體市場
  • 頸動脈EPD市場
  • 腎臟 EPD 市場
  • 下肢EPD市場
• 促進因素和抑制因素
• 競爭性市佔率分析

簡稱

Global Embolic Protection Device Market Report

The global embolic protection device market was valued at $134 million in 2025. Over the forecast period, the market is expected to grow at a CAGR of 1.1% to reach $144 million by 2032.

• The full report suite on the global market for embolic protection devices, or EPDs, covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and average selling price data, while also extending projections through 2032 to provide a clear and forward-looking view of market performance. This description follows the same overall structure and best-practice sequence used in the attached example document, adapted to the specific clinical and commercial dynamics of the EPD market .

This report provides detailed analysis of the global EPD market, including unit sales, procedure numbers, average selling prices, market size, growth trends, market shares and forecasts through 2032, with historical data to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and competitive analysis of the leading companies across major regional markets.

The market is being shaped by a mix of procedural growth and practical limitations. On the positive side, the use of EPDs in lower-limb atherectomy and other high-risk peripheral procedures continues to support unit demand. At the same time, improving imaging and navigation technologies are helping physicians deploy these devices more effectively. On the limiting side, the popularity of carotid endarterectomy, lack of broad physician training in endovascular workflows and the bundling of EPDs with stents continue to restrain market value growth.

Overall, the global embolic protection device market is stable but modest in growth. It remains relevant in selected procedures and patient populations, but broader adoption depends on physician training, reimbursement environment, procedure mix and the continued development of devices that improve ease of use and clinical confidence.

Market Overview

The global embolic protection device market includes devices used during endovascular procedures to prevent embolic debris from traveling downstream and causing complications such as stroke, ischemia or distal vessel blockage. These devices are especially relevant in vascular territories where plaque disruption or thrombotic material can create significant clinical risk during intervention.

Historically, the strongest role for EPDs has been in carotid artery stenting. In carotid procedures, embolic debris can travel to the brain, so protection during the intervention is an important safety consideration. Over time, EPD use has also expanded into selected lower-limb atherectomy procedures and other cases where lesion disruption may release particulate material. This has helped broaden the clinical footprint of the category, although the market remains centered around a relatively small number of indications.

The EPD market is highly tied to the procedure categories in which it is used. It does not create demand independently. Instead, it depends on the volume and growth of carotid stenting, lower-limb atherectomy, selected renal or peripheral interventions and, in some portfolios, cerebral protection related to structural heart procedures. Because of this, the market grows in line with changes in physician preference, clinical guidelines and the overall adoption of protected endovascular treatment.

The market is also evolving with broader technology development in vascular intervention. Imaging and navigation tools are improving how operators assess anatomy, position devices and manage procedural risk. This trend is helping support next-generation EPD development, especially in more complex procedures where real-time vessel assessment can improve decision-making and reduce complications.

Overall, the global EPD market remains a focused safety-oriented category. Its future depends less on mass procedural expansion and more on how physicians balance risk, workflow complexity, reimbursement and the perceived value of embolic protection in selected intervention types.

Market Drivers

Lower-Limb Atherectomy Procedures

One of the main drivers in the global EPD market is the use of embolic protection devices in lower-limb atherectomy procedures. After carotid stenting, this is one of the most frequent use settings for EPDs. Atherectomy procedures can release particulate debris, especially in complex peripheral arterial disease cases, which makes embolic protection relevant in selected interventions.

As the global population ages, the number of procedures performed to treat peripheral arterial disease is expected to rise. This includes atherectomy procedures in lower-limb vessels, where disease burden, calcification and lesion complexity can increase the risk of distal embolization. As these procedure volumes grow, demand for EPDs used in lower-limb cases is expected to rise as well. This is one of the clearest procedural supports for unit growth in the category.

Aging Population and PAD Burden

A broader driver behind the EPD market is the rising burden of peripheral vascular disease and related comorbidities. Older patients are more likely to present with plaque-heavy, calcified or otherwise complex lesions that may benefit from embolic protection when treated endovascularly. Since the market is closely tied to these more advanced procedures, the aging patient base indirectly supports EPD demand.

This trend is especially relevant in peripheral intervention because patients with PAD often also have diabetes, renal disease and other risk factors that make treatment more complicated. As the complexity of cases rises, so does the procedural logic for embolic protection in selected interventions.

High Reimbursement in Germany

Germany has historically been an important driver for parts of the EPD market due to relatively high reimbursement rates in related intervention categories. While this has not applied uniformly across all markets, the German market in particular has benefited from stronger economic support in thrombectomy-linked or related procedural areas. This has helped support use of more advanced endovascular devices in settings where hospitals otherwise might be more cost constrained.

Although reimbursement structures are changing, the historical strength of reimbursement in Germany has been one factor that supported acquisition and use of these devices. In markets without similar support, hospitals often rely more heavily on private settings or selectively limit device use. This makes the German experience especially relevant in understanding where the market has seen better traction.

Market Limiters

Popularity of Endarterectomy

The most important limiter in the global EPD market is the continued popularity of carotid endarterectomy. Although carotid stenting adopted stronger EPD requirements after data such as the CREST trial influenced practice patterns, endarterectomy remains the preferred treatment approach for many physicians worldwide when addressing carotid artery blockages.

This preference matters because carotid stenting is one of the main procedure categories that drives EPD use. If physicians continue favoring open surgical treatment due to lower rates of serious adverse events in the early post-procedure period, then EPD demand remains constrained. In other words, one of the category's core procedural bases grows more slowly when endarterectomy stays dominant.

Lack of Physician Training

Lack of physician training is another major limiter. Neurologists and vascular surgeons are not always trained primarily in endovascular technique, and embolic protection can make a procedure more technically demanding because the physician must manage both the treatment device and the protection device. This added complexity can discourage broader use, especially in lower-volume settings or in regions where endovascular specialization is less developed.

This training gap has a direct effect on penetration. Even if physicians understand the theoretical value of embolic protection, they may be slower to adopt a workflow that adds steps and requires greater procedural confidence. This delays broader uptake and contributes to the market's relatively modest growth profile.

Bundling and Discounting

Bundling is also a significant market limiter. In many markets, companies bundle sales of embolic protection devices with carotid stents or other related products. While this can help place devices and support account relationships, it also encourages heavy discounting and places downward pressure on EPD market value.

This is especially important in countries where the carotid stenting market is less developed. In those environments, suppliers may use aggressive pricing and packaging strategies to protect broader portfolio positions. That supports unit use in some cases, but it can cap revenue growth and keep average selling prices under pressure.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Qualitative Coverage

Market drivers and limiters, growth trends, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Time Frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Regional Coverage

North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.

Data Types Included

Unit sales, average selling prices, procedure numbers, market size and growth trends.

This report is structured to support strategic planning and competitive benchmarking by combining procedure-linked market sizing with pricing analysis and practical clinical context.

Markets Covered and Segmentation

• The report covers the Global Embolic Protection Device Market, further segmented by device type into:

Carotid Embolic Protection Devices

These devices are used primarily in carotid artery stenting procedures to reduce the risk of cerebral embolization and stroke during intervention.

Renal Embolic Protection Devices

These devices are used in selected renal vascular procedures where protection from embolic debris is clinically important.

Lower-Limb Embolic Protection Devices

These devices are used in selected peripheral procedures, especially lower-limb atherectomy, where particulate debris can be released during lesion treatment.

Each segment is analyzed by unit sales, average selling prices and total market value, with forecasts through 2032 and historical data to 2022. This segmentation reflects the main vascular territories in which embolic protection plays a procedural role.

Competitive Analysis

Medtronic entered the U.S. embolic protection device market through its acquisition of Covidien in January 2015, which gave it access to the SpiderFX device that had come through ev3. SpiderFX features a radiopaque band to assist with placement and a stable braided filter design. It holds approvals for carotid, lower-limb and saphenous vein grafting indications. In 2025, Medtronic led the alternative EPD market, and SpiderFX remained the only standalone EPD approved specifically for lower-limb procedures. This gives the company a unique and defensible position in one of the most important non-carotid uses of embolic protection.

Abbott Vascular entered the market in 2006 through the acquisition of Guidant's embolic protection and carotid stent platforms, becoming the first company to offer a carotid-approved EPD. That early presence, combined with physician familiarity, helped support Abbott's durable position in the market. Product evolution also reinforced this role. The Emboshield NAV6 system introduced improved basket design, retrieval functionality and proprietary BareWire technology for more independent wire movement. Abbott also expanded the indication of its RX Accunet EPD, supporting continued relevance in carotid intervention.

Boston Scientific remains another important competitor. Its FilterWire EZ device is used in carotid and saphenous vein graft indications and is designed to provide embolic protection across a range of vessel sizes while maintaining blood flow through a uniform micro-pore filter. Boston Scientific also strengthened its broader protection portfolio through the acquisition of Claret Medical in 2018, which added the Sentinel cerebral protection system for transcatheter aortic valve replacement procedures. By bundling Sentinel with its TAVR product line, Boston Scientific improved portfolio synergy and strengthened its competitive position in protection-related interventions.

Overall, the competitive landscape is shaped by procedure-specific approvals, device familiarity, bundling strategy and the ability to integrate embolic protection into broader vascular and structural heart portfolios.

Technology and Practice Trends

One of the clearest trends in the EPD market is the integration of advanced imaging and navigation tools into endovascular workflows. Better real-time visualization is helping operators assess anatomy, plaque burden and device position more accurately during intervention.

This trend supports more precise embolic protection and can improve operator confidence in more complex cases. Technologies such as intravascular ultrasound and optical coherence tomography are increasingly relevant in this context.

Another important trend is the continued role of lower-limb protection in atherectomy. As atherectomy expands in selected peripheral disease cases, EPD use in lower-limb procedures remains a meaningful area of focus.

The market is also increasingly shaped by portfolio bundling. Rather than competing as isolated devices, EPDs are often positioned alongside stents, atherectomy systems or structural heart products, which affects both pricing and account penetration.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

66 pages of detailed market analysis, segmentation and forecast data.

Methodology Appendix and Acronym Glossary.

Why This Report

Where are the most stable opportunities in the global embolic protection device market through 2032?

How are carotid, renal and lower-limb EPD segments expected to perform across regions?

What role do lower-limb atherectomy growth and physician training play in future unit demand?

How do endarterectomy preference, bundling and reimbursement conditions limit market expansion?

Which competitors hold the strongest positions in carotid and lower-limb embolic protection, and how are they differentiating their products?

How are imaging and navigation advances shaping the next phase of embolic protection device development?

The Global Embolic Protection Device Market Report from iData Research answers these questions with detailed market sizing, pricing analysis, segmentation and competitive intelligence. Use it to benchmark competitors, understand procedural demand and support strategy in a specialized but clinically important vascular device market.

TABLE OF CONTENT

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Embolic Protection Device Market

• 12.1 Executive Summary
  • 12.1.1 Global Embolic Protection Device Market Overview
  • 12.1.2 Competitive Analysis
  • 12.1.3 Procedures Included
  • 12.1.4 Markets Included
  • 12.1.5 Regions Included
• 12.2 Introduction
  • 12.2.1 Protection Mechanism
    • 12.2.1.1 Filter Basket
    • 12.2.1.2 Distal Balloon Occlusion
    • 12.2.1.3 Flow Redirection
• 12.3 Procedure Numbers
• 12.4 Market Overview
  • 12.4.1 By Segment
  • 12.4.2 By Region
• 12.5 Market Analysis And Forecast
  • 12.5.1 Total Embolic Protection Device Market
  • 12.5.2 Carotid Epd Market
  • 12.5.3 Renal Epd Market
  • 12.5.4 Lower-Limb Epd Market
• 12.6 Drivers And Limiters
  • 12.6.1 Market Drivers
  • 12.6.2 Market Limiters
• 12.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 12-1: Embolic Protection Device Market, Global, 2025 & 2032
• Chart 12-2: Embolic Protection Device Procedures, Global, 2025
• Chart 12-3: Embolic Protection Device Procedures by Region, Global, 2022 - 2032
• Chart 12-4: Embolic Protection Device Market by Segment, Global, 2022 - 2032
• Chart 12-5: Embolic Protection Device Market by Region, Global, 2022 - 2032
• Chart 12-6: Leading Competitors, Embolic Protection Device Market, Global, 2025

LIST OF FIGURES

• Figure 12-1: Embolic Protection Device Procedures Covered
• Figure 12-2: Embolic Protection Device Markets Covered
• Figure 12-3: Embolic Protection Device Regions Covered, Global (1 of 2)
• Figure 12-4: Embolic Protection Device Regions Covered, Global (2 of 2)
• Figure 12-5: Embolic Protection Device Procedures by Region, Global, 2022 - 2032
• Figure 12-6: Embolic Protection Device Procedures by Country, North America, 2022 - 2032
• Figure 12-7: Embolic Protection Device Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 12-8: Embolic Protection Device Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 12-9: Embolic Protection Device Procedures by Country, Western Europe, 2022 - 2032
• Figure 12-10: Embolic Protection Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 12-11: Embolic Protection Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 12-12: Embolic Protection Device Procedures by Country, Middle East, 2022 - 2032
• Figure 12-13: Embolic Protection Device Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 12-14: Embolic Protection Device Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 12-15: Embolic Protection Device Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 12-16: Embolic Protection Device Procedures by Country, Africa, 2022 - 2032
• Figure 12-17: Embolic Protection Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 12-18: Embolic Protection Device Market by Region, Global, 2022 - 2032 (US$M)
• Figure 12-19: Embolic Protection Device Market, Global, 2022 - 2032
• Figure 12-20: Units Sold by Region, Embolic Protection Device Market, Global, 2022 - 2032
• Figure 12-21: Average Selling Price by Region, Embolic Protection Device Market, Global, 2022 - 2032 (US$)
• Figure 12-22: Market Value by Region, Embolic Protection Device Market, Global, 2022 - 2032 (US$M)
• Figure 12-23: Carotid EPD Market, Global, 2022 - 2032
• Figure 12-24: Units Sold by Region, Carotid EPD Market, Global, 2022 - 2032
• Figure 12-25: Average Selling Price by Region, Carotid EPD Market, Global, 2022 - 2032 (US$)
• Figure 12-26: Market Value by Region, Carotid EPD Market, Global, 2022 - 2032 (US$M)
• Figure 12-27: Renal EPD Market, Global, 2022 - 2032
• Figure 12-28: Units Sold by Region, Renal EPD Market, Global, 2022 - 2032
• Figure 12-29: Average Selling Price by Region, Renal EPD Market, Global, 2022 - 2032 (US$)
• Figure 12-30: Market Value by Region, Renal EPD Market, Global, 2022 - 2032 (US$M)
• Figure 12-31: Lower-Limb EPD Market, Global, 2022 - 2032
• Figure 12-32: Units Sold by Region, Lower-Limb EPD Market, Global, 2022 - 2032
• Figure 12-33: Average Selling Price by Region, Lower-Limb EPD Market, Global, 2022 - 2032 (US$)
• Figure 12-34: Market Value by Region, Lower-Limb EPD Market, Global, 2022 - 2032 (US$M)
• Figure 12-35: Leading Competitors, Embolic Protection Device Market, Global, 2025